The Online Investor
NUVA Buyback image

NuVasive, Inc. Buyback

OLI recorded this information on 10/24/2017

Company: NuVasive, Inc.
Buyback: NUVA buyback
$Amount Authorized: $100,000,000
Buyback Details: NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced that its Board of Directors approved a share repurchase program authorizing the purchase of up to $100 million of the Company's common stock over a three-year period commencing October 25, 2017.

Nuvasive is a medical device company focused on developing minimally disruptive surgical products and procedurally integrated solutions for spine surgery. Co.'s principal product offering includes a minimally disruptive surgical platform, Maximum Access Surgery. The platform includes Co.'s proprietary software-driven nerve detection and avoidance systems, and Intraoperative Monitoring services and support; MaXcess, an integrated split-blade retractor system; and implants and biologics. Co.'s spine surgery product line offerings, which include products for the thoracolumbar and the cervical spine, are used to enable surgeon access to the spine to perform restorative and fusion procedures.

NUVA SEC Filing Email Alerts Service

Open the NUVA Page at The Online Investor »

Company Name: 
Nuvasive Inc
Stock buyback: 
NUVA buyback
Medical Instruments & Supplies
Number of ETFs Holding NUVA: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 

Open the NUVA Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Hold (2.47 out of 4)
5th percentile
(ranked lower than approx. 95% of all stocks covered)

Analysts' Target Price:
NUVA Stock Forecast

Based on Zacks ABR data;
powered by Xignite

NUVA Buyback Page |

Copyright © 1998 - 2021, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.